IL180361A0 - Compositions and methods for the prevention and control of insulin-induced hypoglycemia - Google Patents
Compositions and methods for the prevention and control of insulin-induced hypoglycemiaInfo
- Publication number
- IL180361A0 IL180361A0 IL180361A IL18036106A IL180361A0 IL 180361 A0 IL180361 A0 IL 180361A0 IL 180361 A IL180361 A IL 180361A IL 18036106 A IL18036106 A IL 18036106A IL 180361 A0 IL180361 A0 IL 180361A0
- Authority
- IL
- Israel
- Prior art keywords
- insulin
- prevention
- compositions
- methods
- control
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 208000013016 Hypoglycemia Diseases 0.000 title 1
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 230000002218 hypoglycaemic effect Effects 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58444904P | 2004-06-29 | 2004-06-29 | |
| PCT/US2005/022812 WO2006004696A2 (en) | 2004-06-29 | 2005-06-27 | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL180361A0 true IL180361A0 (en) | 2007-06-03 |
Family
ID=35783298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL180361A IL180361A0 (en) | 2004-06-29 | 2006-12-26 | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
Country Status (11)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2816114C (en) | 2010-11-03 | 2019-02-12 | Jan Jezek | Novel composition comprising glucagon |
| EP3344231B1 (en) * | 2015-09-04 | 2022-04-13 | Latitude Pharmaceuticals, Inc. | Stabilized glucagon solutions |
| GB201611077D0 (en) | 2016-06-24 | 2016-08-10 | Arecor Ltd | Novel composition |
| EP3576748B1 (en) * | 2017-02-03 | 2023-04-05 | Vanderbilt University | Systems, compositions and methods for treating diabetes |
| CN110913888A (zh) * | 2017-07-14 | 2020-03-24 | Xeris药物公司 | 治疗先天性高胰岛素血症的方法 |
| WO2019108640A1 (en) * | 2017-11-28 | 2019-06-06 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Methods and kits for evaluating metabolism |
| MX2022016265A (es) * | 2020-06-26 | 2023-02-09 | Xeris Pharmaceuticals Inc | Composiciones terapeuticas de liberacion sostenida estable en solventes polares aproticos y metodos de preparacion de los mismos. |
| GB202109087D0 (en) * | 2021-06-24 | 2021-08-11 | Norwegian Univ Sci & Tech Ntnu | Therapeutic methods and devices |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3897551A (en) * | 1971-04-05 | 1975-07-29 | Lilly Co Eli | Iodoglucagons and process for prolonging the biological activity of glucagon |
| US5321008A (en) * | 1991-01-10 | 1994-06-14 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
| WO2004046106A1 (en) * | 2002-11-18 | 2004-06-03 | Pfizer Products Inc. | Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides |
| CA2509755A1 (en) * | 2002-12-27 | 2004-07-22 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
-
2005
- 2005-06-27 ZA ZA200700708A patent/ZA200700708B/xx unknown
- 2005-06-27 WO PCT/US2005/022812 patent/WO2006004696A2/en active Application Filing
- 2005-06-27 CN CNA2005800270476A patent/CN101001638A/zh active Pending
- 2005-06-27 KR KR1020077002164A patent/KR20070029276A/ko not_active Withdrawn
- 2005-06-27 EP EP05787795A patent/EP1778266A4/en not_active Withdrawn
- 2005-06-27 AU AU2005260025A patent/AU2005260025A1/en not_active Abandoned
- 2005-06-27 CA CA002571030A patent/CA2571030A1/en not_active Abandoned
- 2005-06-27 JP JP2007519344A patent/JP2008505087A/ja active Pending
- 2005-06-27 MX MXPA06014970A patent/MXPA06014970A/es not_active Application Discontinuation
-
2006
- 2006-12-26 IL IL180361A patent/IL180361A0/en unknown
-
2007
- 2007-01-10 NO NO20070174A patent/NO20070174L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06014970A (es) | 2007-03-07 |
| WO2006004696A2 (en) | 2006-01-12 |
| JP2008505087A (ja) | 2008-02-21 |
| KR20070029276A (ko) | 2007-03-13 |
| CN101001638A (zh) | 2007-07-18 |
| NO20070174L (no) | 2007-03-13 |
| ZA200700708B (en) | 2009-03-25 |
| EP1778266A2 (en) | 2007-05-02 |
| EP1778266A4 (en) | 2009-09-09 |
| CA2571030A1 (en) | 2006-01-12 |
| AU2005260025A1 (en) | 2006-01-12 |
| WO2006004696A3 (en) | 2006-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1578437A4 (en) | COMPOSITIONS AND METHODS FOR PREVENTING AND REDUCING INSULIN-INDUCED HYPOGLYCEMIA | |
| IL181896A0 (en) | Methods and compositions for the treatment of hyperlipidemia | |
| AU2005339139A8 (en) | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease | |
| IL182863A0 (en) | Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof | |
| PT1755391E (pt) | Métodos e composições para o tratamento de neuropatias | |
| SI1771201T1 (sl) | Sestavki in metode za zdravljenje ali preprečevanje z oksalatom-povezanih bolezni | |
| IL183709A0 (en) | Compositions and methods for treating conditions of the nail unit | |
| IL183986A0 (en) | Pharmaceutical compounds and compositions | |
| IL180361A0 (en) | Compositions and methods for the prevention and control of insulin-induced hypoglycemia | |
| ZA200800448B (en) | Methods and compositions for the prevention and treatment of inflammatory disease | |
| IL187565A0 (en) | Compositions and methods for the treatment or prevention of chemoresistant neoplasia | |
| IL186325A0 (en) | Tizanidine compositions and methods of treatment using the compositions | |
| PL1762219T3 (pl) | Fotoochronne i/lub fotoimmunoochronne kompozycje do skóry i ich zastosowania | |
| ZA200703087B (en) | Methods and compositions for the treatment of hyperlipidemia | |
| IL186337A0 (en) | Stannsoporfin compositions and administration | |
| PT2474528E (pt) | Compostos antineoplásicos e composições farmacêuticas dos mesmos | |
| EP1810689A4 (en) | MEANS FOR THE PREVENTION AND / OR TREATMENT OF DIABETES | |
| EP1812797A4 (en) | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HYPERPROLIFERATIVE DISEASES | |
| EP1776956A4 (en) | PREVENTIVE AND / OR THERAPEUTIC AGENT FOR CALCIPENIA | |
| GB0424051D0 (en) | Compounds and compositions | |
| IL180526A (en) | Composition for the prevention and treatment of allergic inflammatory disease | |
| HU0400960D0 (en) | Composition for controlling louses and its larvae and method for controlling louses | |
| GB0423292D0 (en) | Compounds and compositions | |
| AU2004901220A0 (en) | Compositions and methods for treatment disease | |
| HK1114021A (en) | Tizanidine compositions and methods of treatment using the compositions |